Mesoblast Limited (MSB.AX) Stock Overview
Explore Mesoblast Limited’s financial performance, market position, analyst ratings, and future outlook.
Mesoblast Limited (MSB.AX)
Key Financials
Key Financials
Market Cap
2.5B
P/E Ratio
-22.46
EPS (TTM)
$-0.09
ROE
-0.14%
MSB.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mesoblast Limited (MSB.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.17.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.46 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.